跳至主要内容
临床试验/NCT05664958
NCT05664958已完成4 期

Erector Spinae Plane Block With Liposomal Bupivacaine for Post Cesarean Delivery Analgesia: A Pilot Study

Duke University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年4月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
Postoperative Oxycodone Consumption 0- 48 Hours After Cesarean Delivery

研究概览

简要总结

The purpose of this pilot study is to assess the analgesic efficacy of Erector Spinae Plane block (ESPB) with liposomal bupivacaine in women undergoing cesarean delivery and receiving a postoperative multimodal analgesic regimen as assessed by the dose of rescue postoperative opioids compared to a historical control group of women receiving the same multimodal regimen but with no truncal blocks. This will be a case control study with a prospective and a retrospective component. Women undergoing elective cesarean delivery under spinal or combined spinal epidural anesthesia will be approached to participate in the prospective open label component of the study. Cases will be matched in a 1:4 ratio by age, race, history of prior cesarean delivery, and insurance status with historical controls who received the same multimodal analgesic regimen but no truncal blocks. We plan to enroll 30 subjects for the prospective arm of the study and 120 for the retrospective arm.

详细描述

This will be a case control study with a prospective and a retrospective component. Women undergoing elective cesarean delivery under spinal or combined spinal epidural anesthesia will be approached to participate in the prospective open label component of the study. Those women will receive the standard of care intraoperative and postoperative analgesic regimen used at Duke university incorporating 100 mcg intrathecal morphine, intraoperative acetaminophen 975 mg PR and ketorolac 15 mg IV and postoperative scheduled oral acetaminophen 975 mg every 6 hours, scheduled 15 mg IV ketorolac for 3 doses every 6 hours followed by oral ibuprofen 600 mg every 6 hours. At the end of surgery, a bilateral ESPB will be performed under ultrasound guidance using 133 mg liposomal bupivacaine and 20 ml bupivacaine 0.25% per side.

Cases will be matched in a 1:4 ratio by age, race, history of prior cesarean delivery, and insurance status with historical controls who received the same multimodal analgesic regimen but no truncal blocks.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients ≥18 years of age with a term pregnancy of 37 to 42 weeks and American Society of Anesthesiologists Physical Status Classification II or III scheduled to undergo elective CD.

排除标准

  • ≥3 prior CDs, pre-pregnancy body mass index >40 kg/m2, planned concurrent surgical procedure other than tubal ligation, chronic pain or chronic opioid therapy, any clinically significant event or condition uncovered during surgery (eg, excessive bleeding, acute sepsis) that might render the patient medically unstable or complicate the patient's postsurgical course, or allergy or contraindication to any component of the multimodal analgesic regimen.

研究组 & 干预措施

ESP Block

Experimental

Standard of care analgesic regimen with ESP Block

干预措施: Erector Spinae Plane (ESP) Block (Procedure)

ESP Block

Experimental

Standard of care analgesic regimen with ESP Block

干预措施: bupivacaine liposome injectable suspension (Drug)

ESP Block

Experimental

Standard of care analgesic regimen with ESP Block

干预措施: bupivacaine (Drug)

结局指标

主要结局

Postoperative Oxycodone Consumption 0- 48 Hours After Cesarean Delivery

时间窗: 0-48 hours after cesarean delivery

Total dose of rescue oxycodone used in mg 0- 48 hours after cesarean delivery

次要结局

  • Postoperative Opioid Consumption at 24 Hours(0-24 hours)
  • Time to First Postsurgical Opioid Rescue Medication(0-48 hours)
  • Area Under the Curve (AUC) of Verbal Rating Scale (VRS) Pain Intensity Scores(0-48 hours)
  • Number of Participants With Postoperative Nausea and Vomiting(0-48 hours)
  • Number of Participants With the Need for Rescue Antiemetics(0-48 hours)
  • Number of Participants With Pruritus(0-48 hours)
  • Number of Participants With the Need for Rescue Antipruritics(0-48 hours)
  • Number of Participants Not Receiving Any Rescue Opioids Postoperatively(0-48 hours)

研究者

发起方
Duke University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验